Celyad Oncology

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CYAD and other ETFs, options, and stocks.

About CYAD

Celyad Oncology SA is a clinical-stage biotechnology company, which focuses on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. It operates through the following segments: Cardiology and Immuno-Oncology. 

CEO
Michel E. Lussier
CEOMichel E. Lussier
Employees
103
Employees103
Headquarters
Mont-Saint-Guibert, Walloon Region
HeadquartersMont-Saint-Guibert, Walloon Region
Founded
2007
Founded2007
Employees
103
Employees103

CYAD Key Statistics

Market cap
31.41M
Market cap31.41M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
8.08K
Average volume8.08K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$5.58
52 Week high$5.58
52 Week low
$1.30
52 Week low$1.30

CYAD Earnings

-$0.74
-$0.49
-$0.25
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
per share
Estimated per share
Actual
Available Aug 5
ActualAvailable Aug 5
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.